News

Healthcare is undervalued despite being the top sector for earnings growth, making it an attractive investment with solid fundamentals and the potential for explosive returns in 2025. Investing in healthcare ETFs or individual undervalued healthcare stocks can capitalize on the sector's recovery and expected double-digit growth through 2026. Screening for blue-chip healthcare stocks with solid fundamentals and fair valuations can yield superior returns, including these five coiled spring blue chips.

Verizon sports a fat dividend yield of 6.6% and plenty enough cash flow to cover it. Financial services powerhouse Citigroup offers a more modest but still solid 3.6% yield.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Despite deteriorating fundamentals and bad press, I bought a half-sized position in CVS due to its historical and relative cheapness, attractive yield, and potential for recovery. CVS trades below 9x forward PE, indicating it's priced for further deterioration, but it's historically and relatively cheap compared to peers like CI and UNH. CVS offers a 4.6% yield, making it an attractive income security, especially compared to treasury rates and other high-yield securities.

The latest trading day saw CVS Health (CVS) settling at $57.98, representing a +0.78% change from its previous close.

Certain stocks stand out as attractively priced and well-positioned for potential appreciation for value investors focused on long-term growth with a defensive approach. While not isolated from risks and challenges, the three companies discussed below trade at favorable valuations based on P/E ratios and earnings growth and offer the added benefit of dividend income, making them appealing to those seeking steady returns and compounding growth.

CVS Health announces that nearly 400 CVS Pharmacy locations in Massachusetts have started offering hormonal contraceptive prescribing services.

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.